Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Specific immunoradiometric assay of insulin-like growth factor I with use of monoclonal antibodies

Journal Article · · Clin. Chem. (Winston-Salem, N.C.); (United States)
OSTI ID:5520830
We identified two monoclonal antibodies that bind spatially distinct epitopes on insulin-like growth factor I (IGF-I). Using these two antibodies, we developed a simultaneous, two-site immunoradiometric assay (IRMA) specific for IGF-I. This IRMA has no detectable cross reactivity with insulin, proinsulin, prolactin, or somatotropin, and less than 2% crossreactivity with IGF-II. The assay response varies linearly with IGF-I concentrations of 0-800 micrograms/L in serum; the detection limit is about 10 micrograms/L. A comparison of 26 IGF-I serum values from the IRMA and from a previously reported IGF-I specific RIA gave a correlation coefficient of 0.96 with no substantial bias (slope = 1.10). IGF-I values for serum, as an aid in assessing growth abnormalities, are easily (only three pipetting steps) obtained in less than 4 h.
Research Organization:
Mallinckrodt, Inc., St. Louis, MO
OSTI ID:
5520830
Journal Information:
Clin. Chem. (Winston-Salem, N.C.); (United States), Journal Name: Clin. Chem. (Winston-Salem, N.C.); (United States) Vol. 33:11; ISSN CLCHA
Country of Publication:
United States
Language:
English